Transgene participera à l’Investor Access
Filed with Euronext · · 2 pages · French
Watch Transgene's latest callTransgene (Euronext:TNG) Q4 2025 Earnings Call · Replay · Mar 24Read the transcript of Transgene (Euronext:TNG) Q4 2025 Earnings CallEarlier from Transgene
- Transgene Extends its myvac® Platform, Further Establishing its Position as a Key Player in the Rapidly Emerging Individualized Cancer Immunotherapy Field
- Mise à disposition du Rapport Financier Semestriel au 30 juin 2026
- Transgene and ProBioGen Expand Strategic Partnership with Additional License Agreement for AGE1.CR.pIX Cell Line
- Transgene étend son partenariat stratégique avec ProBioGen par un nouvel accord de licence pour la lignée cellulaire AGE1.CR.pIX
- Transgene and Nec Report 100% Three-Year Disease-Free Survival with TG4050 and Publish Phase 1 Results in Nature Communications
Later from Transgene
- Transgene to Participate in Investor Access
- Transgene Will Present a Poster on Preclinical Data from a Novel Oncolytic Virus at SITC 2026
Follow Transgene into a list and get an email when it puts out news.
Follow Transgene